26/03/2025 09:23
EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Conference br/ Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 br/br/ 26.03.2025 / 09:23... Lire...
21/03/2025 07:07
EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Annual Report br/ Heidelberg Pharma announces financial figures and reports on successful business performance in 2024 br/br/ 21.03.2025... Lire...
13/03/2025 07:30
EQS-News: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Contract br/ Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty br/br/ 13.03.2025 / 07:30 CET/CESTbr/ The issuer... Lire...
13/03/2025 00:31
EQS-Adhoc: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Heidelberg Pharma AG / Key words: Contractbr/ Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty br/br/ 13March2025 / 00:31 CET/CESTbr/ Disclosure of an inside information acc. to... Lire...
13/01/2025 08:17
EQS-News: Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Study br/ Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP101 Targeting Multiple Myeloma... Lire...
06/11/2024 10:02
EQS-News: Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Conference br/ Heidelberg Pharma: Promising New Clinical Data on Lead ADCCandidate HDP101 to be Presented at ASH Annual Meeting 2024... Lire...
24/10/2024 11:03
EQS-News: Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Conference br/ Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024 br/br/ 24.10.2024 /... Lire...
10/10/2024 07:06
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: 9 Month figures br/ Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024 br/br/ 10.10.2024 / 07:06... Lire...
01/10/2024 17:29
EQS-News: Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Study results br/ Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP101 Presented at IMS 2024 Demonstrating Complete Remission in One... Lire...